TNF-α-induced cardiomyocyte apoptosis contributes to cardiac dysfunction after coronary microembolization in mini-pigs

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 10, 2014, Pages 1953-1963

  Chen, Zhang Wei ^a   Qian, Ju Ying ^a   Ma, Jian Ying ^a   Chang, Shu Fu ^a   Yun, Hong ^a   Jin, Hang ^a   Sun, Ai Jun ^a   Zou, Yun Zeng ^a   Ge, Jun Bo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Coronary microembolization; Tumour necrosis factor alpha

Indexed keywords

SUIDAE;

INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ANIMAL; APOPTOSIS; BLOOD; CARDIAC MUSCLE CELL; CELL CULTURE; CELL PROLIFERATION; COMPLICATION; CORONARY ARTERY BLOOD FLOW; DRUG EFFECTS; EMBOLISM; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEMODYNAMICS; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PIG; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CORONARY CIRCULATION; EMBOLISM; FEMALE; HEMODYNAMICS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MALE; MYOCYTES, CARDIAC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROKE VOLUME; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 84908076618     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12342     Document Type: Article

References (38)

1. Skyschally A, Leineweber K, Gres P, et al. Coronary microembolization. Basic Res Cardiol. 2006; 101: 373-82.
2. Heusch G, Kleinbongard P, Böse D, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009; 120: 1822-36.
3. Breuckmann F, Nassenstein K, Bucher C, et al. Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study. JACC Cardiovasc Imaging. 2009; 2: 121-30.
4. Hori M, Inoue M, Kitakaze M, et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. Am J Physiol. 1986; 250: H509-18.
5. Dörge H, Neumann T, Behrends M, et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol. 2000; 279: H2587-92.
6. Skyschally A, Schulz R, Erbel R, et al. Reduced coronary and inotropic reserves with coronary microembolization. Am J Physiol Heart Circ Physiol. 2002; 282: H611-4.
7. Dörge H, Schulz R, Belosjorow S, et al. Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol. 2002; 34: 51-62.
8. Thielmann M, Dörge H, Martin C, et al. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-α, and sphingosine. Circ Res. 2002; 90: 807-13.
9. Kleinbongard P, Böse D, Baars T, et al. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. Circ Res. 2001; 108: 344-52.
10. Skyschally A, Haude M, Dörge H, et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation. 2004; 109: 2337-42.
11. Chen Z, Qian J, Ma J, et al. Glucocorticoid ameliorates early cardiac dysfunction after coronary microembolization and suppresses TGF-β1/Smad3 and CTGF expression. Int J Cardiol. 2013; 167: 2278-84.
12. Skyschally A, Gres P, Hoffmann S, et al. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res. 2007; 100: 140-6.
13. Arras M, Strasser R, Mohri M, et al. Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol. 1998; 93: 97-107.
14. Böse D, Leineweber K, Konorza T, et al. Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am J Physiol Heart Circ Physiol. 2007; 292: H2295-9.
15. Kleinbongard P, Heusch G, Schulz R. TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther. 2010; 127: 295-314.
16. Mizuochi Y, Okajima K, Harada N, et al. Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Transl Res. 2007; 149: 223-30.
17. Sato H, Watanabe A, Tanaka T, et al. Regulation of the human tumor necrosis factor-alpha promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors. J Mol Cell Cardiol. 2003; 35: 1197-205.
18. Chanani NK, Cowan DB, Takeuchi K, et al. Differential effects of amrinone and milrinone upon myocardial inflammatory signaling. Circulation. 2002; 106: I284-9.
19. Hikoso S, Yamaguchi O, Higuchi Y, et al. Pressure overload induces cardiac dysfunction and dilation in signal transducer and activator of transcription 6-deficient mice. Circulation. 2004; 110: 2631-7.
20. Ozsoy HZ, Sivasubramanian N, Wieder ED, et al. Oxidative stress promotes ligand-independent and enhanced ligand-dependent tumor necrosis factor receptor signaling. J Biol Chem. 2008; 283: 23419-28.
21. Chu SC, Marks-Konczalik J, Wu HP, et al. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun. 1998; 248: 871-8.
22. Funakoshi H, Kubota T, Machida Y, et al. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol. 2002; 282: H2159-66.
23. Varfolomeev E, Vucic D. (Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways. Cell Cycle. 2008; 7: 1511-21.
24. Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation. 1998; 97: 1375-81.
25. Li S, Zhong S, Zeng K, et al. Blockade of NF-kappaB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats. Basic Res Cardiol. 2010; 105: 139-50.
26. Li L, Su Q, Wang Y, et al. Effect of atorvastatin (Lipitor) on myocardial apoptosis and caspase-8 activation following coronary microembolization. Cell Biochem Biophys. 2010; 61: 399-406.
27. Zhang QY, Ge JB, Chen JZ, et al. Mast cell contributes to cardiomyocyte apoptosis after coronary microembolization. J Histochem Cytochem. 2006; 54: 515-23.
28. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008; 214: 149-60.
29. Baumgart D, Liu F, Haude M, et al. Acute plaque rupture and myocardial stunning in patient with normal coronary arteriography. Lancet. 1995; 346: 193-4.
30. Saber RS, Edwards WD, Bailey KR, et al. Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. J Am Coll Cardiol. 1993; 22: 1283-8.
31. Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part II: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation. 2004; 109: 310-5.
32. Canton M, Skyschally A, Menabò R, et al. Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur Heart J. 2006; 27: 875-81.
33. van Empel VP, Bertrand AT, Hofstra L, et al. Myocyte apoptosis in heart failure. Cardiovasc Res. 2005; 67: 21-9.
34. Wencker D, Chandra M, Nguyen K, et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest. 2003; 111: 1497-504.
35. Wolf BB, Green DR. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem. 1999; 274: 20049-52.
36. Communal C, Sumandea M, de Tombe P, et al. Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci USA. 2002; 99: 6252-6.
37. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci. 2001; 26: 61-6.
38. Antonsson B, Montessuit S, Sanchez B, et al. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem. 2001; 276: 11615-23.